BLEND

Vela

The cannabis blend for relief, with very little euphoria. 4:1 CBD | THC ratio.

Drops

600 mg

Price

80.00

Vela Drops

Formula

CBD Content Approx: 2.0 % / 450 mg*
THC Content Approx: 0.5 % / 150 mg*
CBD:THC 4:1

Major Terpenes

B-Myrcene Trans-Caryophylene

Dosing Units

0.5mg/drop for sublingual drops (600mg)

Total Doses

Approx: 1200 drops per 600 mg (30ml bottle)

Average
Price

30 day
50 day
70 day

Vela

With a 4:1 CBD | THC ratio, Vela is generally considered a good introduction to cannabis as an adjunct therapy, containing four times the concentration of CBD relative to THC. With minimal THC, Vela produces very little psychoactivity/euphoria yet both cannabinoids work synergistically to increase its effectiveness.

Why the Fluent Strain Names?

Common strain names are unreliable for describing a particular genetic variant (a.k.a phenotype or strain) since their chemical expression varies tremendously from grower to grower. Fluent strain names represent the specific phenotype that we grow, offering you a true, consistent representation of our products.

key Benefits:

Tinctures are absorbed sublingually, so essential cannabinoids are absorbed directly into the bloodstream. Effects are delayed through the absorption process but are prolonged. The application is very discreet, with no odor.

Instructions:

Patients are recommended to initiate treatment with 2.5 mg (meaning 2 drops). After 5-7 days, the dose can be gradually increased to 5 mg twice a day (4 drops, twice a day).

Patients who are able to tolerate 5 mg twice daily may benefit from a dosage increase. The maximum dosage recommended is 10 mg twice daily (8 drops, twice a day). This should be progressed over several weeks, as tolerated.

Warnings:

This product contains MCT oil. Those with a coconut allergy should consult their physician before consuming.

Contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in this strain.
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.